Inogen

INGN47

$9.69arrow_drop_down0.61%-$0.06

INGN47

$9.69

arrow_drop_down0.61%-$0.06

Performance History

Key Stats
Open	$9.91
Prev. Close	$9.75
EPS	-3.97
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$231.26M
PE Ratio	-

	LOW	HIGH
Day Range	9.31	9.91
52 Week Range	4.13	13.33

Ratios

Revenue	-





EPS	-3.97

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Inogen (INGN)

Inogen Inc (INGN) is a medical technology company that specializes in the development and manufacturing of innovative oxygen therapy products. The company was founded in 2001 with the goal of improving the lives of individuals with respiratory conditions. Inogen's main product is the Inogen One, a portable oxygen concentrator that provides a reliable source of oxygen for patients on the go. The Inogen One has revolutionized the oxygen therapy industry, offering a lightweight and compact solution that allows patients to maintain an active lifestyle. With the Inogen One, patients no longer need to rely on heavy oxygen tanks or stationary concentrators.

Over the years, Inogen has experienced significant growth and success. The company's stock price history reflects this positive trajectory, with consistent increases in value. Investors who purchased shares of INGN have seen substantial returns on their investment. Inogen's stock is highly sought after, as the company continues to dominate the oxygen therapy market. The demand for their products is driven by an aging population and an increasing prevalence of respiratory conditions. With a focus on innovation, quality, and customer satisfaction, Inogen remains at the forefront of the industry.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Nabil Shabshab
Headquarters: Goleta
Employees: 1026
Exchange: NASDAQ

Keep an eye on Inogen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Inogen 's (INGN) price per share?

The current price per share for Inogen (INGN) is $9.69. The stock has seen a price change of -$0.06 recently, indicating a -0.62% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Inogen (INGN)?

For Inogen (INGN), the 52-week high is $13.33, which is 37.56% from the current price. The 52-week low is $4.13, the current price is 134.62% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Inogen (INGN) a growth stock?

Inogen (INGN) has shown an average price growth of 0.41% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Inogen as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Inogen (INGN) stock price performance year to date (YTD)?

As of the latest data, Inogen (INGN) has a year-to-date price change of 70.9%. Over the past month, the stock has experienced a price change of -25.35%. Over the last three months, the change has been 21.58%. Over the past six months, the figure is 21.66%. Looking at a longer horizon, the five-year price change stands at -79.72%.

help

Is Inogen (INGN) a profitable company?

Inogen (INGN) has a net income of -$102.45M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 43.26% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -7.49% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $136.54M. Operating income is noted at -$64.38M. Furthermore, the EBITDA is -$34.31M.

help

What is the market capitalization of Inogen (INGN)?

Inogen (INGN) has a market capitalization of $231.26M. The average daily trading volume is 196.28K, indicating the stock's liquidity and investor engagement.